Target Information
Target General Information | Top | |||||
---|---|---|---|---|---|---|
Target ID |
T87237
(Former ID: TTDI01238)
|
|||||
Target Name |
Cell differentiation (CD)
|
|||||
Gene Name |
NO-GeName
|
|||||
Target Type |
Clinical trial target
|
[1] | ||||
Disease | [+] 4 Target-related Diseases | + | ||||
1 | Acute myeloid leukaemia [ICD-11: 2A60] | |||||
2 | Malignant haematopoietic neoplasm [ICD-11: 2B33] | |||||
3 | Myelodysplastic syndrome [ICD-11: 2A37] | |||||
4 | Myeloproliferative neoplasm [ICD-11: 2A20] | |||||
UniProt ID |
Drugs and Modes of Action | Top | |||||
---|---|---|---|---|---|---|
Clinical Trial Drug(s) | [+] 1 Clinical Trial Drugs | + | ||||
1 | FF-10501-01 | Drug Info | Phase 1/2 | Acute myeloid leukaemia | [2] | |
Mode of Action | [+] 1 Modes of Action | + | ||||
Stimulator | [+] 1 Stimulator drugs | + | ||||
1 | FF-10501-01 | Drug Info | [2] |
References | Top | |||||
---|---|---|---|---|---|---|
REF 1 | Fujifilm Initiates Phase I Clinical Trial in Japan for the Anticancer Agent "FF-10501" in Patients with Relapsed or Refractory Myelodysplastic Syndromes. FUJIFILM Corporation. June 6, 2013. | |||||
REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.